Decision regret after reirradiation of the primary site in patients with prostate cancer
DR was mild among prostate cancer patients after reirradiation to the primary site. PRO on symptom burden and shared decision making may be associated with DR. These findings should be validated and may inform treatment decisions on local salvage therapy.
Authors
- Bilgesu Sahin Öztürk
- Olaf Wittenstein (ORCID: https://orcid.org/0000-0003-4127-3139)
- Alexander Fabian (ORCID: https://orcid.org/0000-0003-2415-527X)
- Oliver Blanck (ORCID: https://orcid.org/0000-0003-1391-1308)
- David A. Krug (ORCID: https://orcid.org/0000-0001-8811-5416)
- Frank‐André Siebert
- Severin Rodler (ORCID: https://orcid.org/0000-0002-7600-6535)
- Stefan Huttenlocher (ORCID: https://orcid.org/0000-0002-6368-3166)
- Claudia Schmalz (ORCID: https://orcid.org/0000-0002-7950-5647)
- Christian Schulz (ORCID: https://orcid.org/0000-0002-4861-4517)
- Christof van der Horst
- Lars Haack
Institutions
- Universität Hamburg (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- University Hospital Schleswig-Holstein (DE)
- SAPHIR Radiochirurgie (DE)
- Clinical Research Center Kiel (DE)
- University of Lübeck (DE)
Publication Details
- Journal
- Clinical and Translational Radiation Oncology
- Published
- 2025-07-19
- DOI
- https://doi.org/10.1016/j.ctro.2025.101019
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00